Nosopharm

About:

Nosopharm is a biotechnology company engaged in the research and development of anti-infective drugs.

Website: http://nosopharm.com/

Twitter/X: Nosopharm

Top Investors: Bpifrance, Auriga Partners, KREAXI, Alto Invest

Description:

Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery. Nosopharm addresses the unmet medical need of the bacterial multidrug resistance to antibiotics, a very concerning issue for hospital-acquired infections. Nosopharm has set up an innovative anti-infective drug discovery platform based on the medicinal mining of the microbial biodiversity. The company has developed a unique expertise in the screening and the characterization of bioactive secondary metabolites produced by an original microbial bioresource: the bacterial genera Xenorhabdus and Photorhabdus.